OrbiMed Advisors LLC's Form 4 filing
Xtant Medical Holdings, Inc. (XTNT) · filed Apr 14, 2025
- Accession no.
- 0000947871-25-000392
- Filed
- Apr 14, 2025, 7:14 PM ET
- Trade date
- Apr 10, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $30.7M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| Orbimed ROF II LLCCIK 0001767936 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2025 | Common Stock | SSaleDisposed | −56,004,974 | $0.42 | −$23,522,089.08 | 0 | Indirect | |
| Apr 10, 2025 | Common Stock | SSaleDisposed | −17,109,618 | $0.42 | −$7,186,039.56 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.